Quinfosys™ QuDrugForge

Unlock the power of in silico biochemistry. QuDrugForge integrates quantum molecular screening with generative intelligence to identify high-affinity lead candidates.

• Project-centric discovery workflows

  Organize chemical space explorations by target disease programs, structural targets, and active runs.

• AI/ML model registry

  Deploy, benchmark, and track computational molecular predictors, QSAR arrays, and open-source models.

• Docking and GNINA analysis

  Perform structural binding checks with AutoDock and deep convolutional GNINA neural scorers.

• Quantum reranking

  Obtain high-accuracy compound scoring with quantum chemical binding affinity models.

• ADMET and toxicity screening

  Identify high-risk ADMET and developmental flags early with instant predictive dashboards.

• Report and validation exports

  Synthesize full research evidence portfolios, logs, and structured raw tables with one click.